These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 7379059)

  • 1. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
    Moran RE; Straus MJ
    Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo cell cycle synchronization of the murine sarcoma 180 tumor following alternating periods of hydroxyurea blockade and release.
    Tomita K; Plager JE
    Cancer Res; 1979 Nov; 39(11):4407-11. PubMed ID: 498073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-beta-D-arabinofuranosylcytosine with adriamycin.
    Ritch PS; Occhipinti SJ; Cunningham RE; Shackney SE
    Cancer Res; 1981 Oct; 41(10):3881-4. PubMed ID: 7284997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
    Nakayama T; Sakamoto S; Sassa S; Suzuki S; Kudo H; Nagasawa H
    Anticancer Res; 2005; 25(1A):157-60. PubMed ID: 15816533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new anti-cancer principle isolated from Gymnosporia rothiana Laws, and its use in attaining cures in L1210 leukaemia in combination with "S" phase sensitive drugs.
    Alate AD; Khandalekar DD; Amonkar AJ; Adwankar MK; Sahasrabudhe MB
    Biomedicine; 1978 Oct; 28(5):270-3. PubMed ID: 743552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
    Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pulse and continuous intravenous infusion of cis-diamminedichloroplatinum on L1210 leukemia in vivo.
    Moran RE; Straus MJ
    Cancer Res; 1981 Dec; 41(12 Pt 1):4993-6. PubMed ID: 7198009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F; Cadman E
    Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of "early" thymidine/inosine protection as an adjunct to methotrexate therapy.
    Eleff M; Franks PE; Wampler GL; Collins JM; Goldman ID
    Cancer Treat Rep; 1985; 69(7-8):867-74. PubMed ID: 2410122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial iron chelator-induced cell cycle synchronization in L1210 cells: potential in combination chemotherapy.
    Bergeron RJ; Ingeno MJ
    Cancer Res; 1987 Nov; 47(22):6010-6. PubMed ID: 3664504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle synchronization of the mouse S-180 tumor following alternating period of hydroxyurea-blockade and release.
    Tomita K
    Nihon Seikeigeka Gakkai Zasshi; 1979 Nov; 53(11):1687-95. PubMed ID: 528803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis by bromodeoxyuridine/DNA assay of cell cycle perturbation of methotrexate-treated mouse L1210 leukemia cells.
    Tsurusawa M; Niwa M; Katano N; Fujimoto T
    Cancer Res; 1988 Aug; 48(15):4288-93. PubMed ID: 3390825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy involving alpha-difluoromethylornithine and 1-beta-D-arabinofuranosylcytosine in murine L1210 leukemia.
    Prakash NJ; Sunkara PS
    Cancer Res; 1983 Jul; 43(7):3192-6. PubMed ID: 6406054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effects of dexamethasone restricted to noncycling, early G1-phase cells of L1210 leukemia.
    Smets LA; Bout B; Brouwer M; Tulp A
    J Cell Physiol; 1983 Sep; 116(3):397-403. PubMed ID: 6885934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of hydroxyurea and ionizing radiation in human cervical carcinoma cells.
    Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
    Cancer J Sci Am; 1997; 3(3):163-73. PubMed ID: 9161782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cell cycles of cancer cells and chemotherapy--flow cytometric observation of the effects of chemotherapeutic agents on cell kinetics of cultured human lung cancer cells].
    Shimizu T
    Hokkaido Igaku Zasshi; 1983 Sep; 58(5):467-82. PubMed ID: 6662482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
    Traganos F; Israel M; Silber R; Seshadri R; Kirschenbaum S; Potmesil M
    Cancer Res; 1985 Dec; 45(12 Pt 1):6273-9. PubMed ID: 4063977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
    Walsh CT; Craig RW; Agarwal RP
    Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
    Cadman E; Eiferman F
    J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.